These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32375250)

  • 1. Tumor Endothelial Cell-A Biological Tool for Translational Cancer Research.
    Annan DA; Kikuchi H; Maishi N; Hida Y; Hida K
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hepatocellular carcinoma tumor-derived endothelial cells manifest increased angiogenesis capability and drug resistance compared with normal endothelial cells.
    Xiong YQ; Sun HC; Zhang W; Zhu XD; Zhuang PY; Zhang JB; Wang L; Wu WZ; Qin LX; Tang ZY
    Clin Cancer Res; 2009 Aug; 15(15):4838-46. PubMed ID: 19638466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting.
    Bikfalvi A; Bicknell R
    Trends Pharmacol Sci; 2002 Dec; 23(12):576-82. PubMed ID: 12457776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of Tumor Endothelial Cells in Cancer Progression.
    Hida K; Maishi N; Annan DA; Hida Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of new drugs in angiogenesis.
    Ziche M; Donnini S; Morbidelli L
    Curr Drug Targets; 2004 Jul; 5(5):485-93. PubMed ID: 15216914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango.
    Thijssen VL; van Beijnum JR; Mayo KH; Griffioen AW
    Curr Pharm Des; 2007; 13(35):3576-83. PubMed ID: 18220794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor angiogenesis and therapy.
    Cao Y
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S340-3. PubMed ID: 16507405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging tumor angiogenesis.
    Red-Horse K; Ferrara N
    J Clin Invest; 2006 Oct; 116(10):2585-7. PubMed ID: 17016553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of molecular and functional alterations of tumor endothelial cells to design anti-angiogenic strategies.
    Bussolati B; Deregibus MC; Camussi G
    Curr Vasc Pharmacol; 2010 Mar; 8(2):220-32. PubMed ID: 19485921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of novel antiangiogenic therapies.
    Scappaticci FA
    Expert Opin Investig Drugs; 2003 Jun; 12(6):923-32. PubMed ID: 12783597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
    Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenesis, anti-VEGF(R) and outlook.
    Petersen I
    Recent Results Cancer Res; 2007; 176():189-99. PubMed ID: 17607926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of tumor endothelial cells.
    Hida K; Ohga N; Akiyama K; Maishi N; Hida Y
    Cancer Sci; 2013 Nov; 104(11):1391-5. PubMed ID: 23930621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-tumor target--beneficial site for antiangiogenic cancer therapy?
    Cao Y
    Nat Rev Clin Oncol; 2010 Oct; 7(10):604-8. PubMed ID: 20683436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of selected patents for cancer therapy targeting tumor angiogenesis.
    Kirstein MN; Moore MM; Dudek AZ
    Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):153-61. PubMed ID: 18221033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The great escape; the hallmarks of resistance to antiangiogenic therapy.
    van Beijnum JR; Nowak-Sliwinska P; Huijbers EJ; Thijssen VL; Griffioen AW
    Pharmacol Rev; 2015; 67(2):441-61. PubMed ID: 25769965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
    Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
    Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
    Quintieri L; Selmy M; Indraccolo S
    Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
    Glade Bender J; Cooney EM; Kandel JJ; Yamashiro DJ
    Drug Resist Updat; 2004; 7(4-5):289-300. PubMed ID: 15533766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.